## Drug of Choice for CSOM with Active Discharge **Key Point:** Fluoroquinolone otic drops (ciprofloxacin or ofloxacin) are the first-line topical agents for chronic suppurative otitis media with active drainage, particularly when Pseudomonas aeruginosa is cultured. ## Why Ciprofloxacin? ### Spectrum & Efficacy - Excellent activity against Pseudomonas aeruginosa (the most common pathogen in CSOM) - Also covers Staphylococcus aureus and other gram-negative organisms - Achieves high concentrations in middle ear when applied topically - Penetrates biofilms effectively ### Safety Profile - Safe for use in perforated tympanum (unlike aminoglycosides) - Non-ototoxic — critical advantage in CSOM where tympanic membrane is already compromised - Does not cause local irritation or allergic reactions ### Clinical Advantage - Reduces discharge and promotes healing of perforation - Prevents recurrent infections - Can be used for prolonged periods without risk of ototoxicity ## Comparative Table: Topical Otic Agents in CSOM | Agent | Spectrum | Ototoxicity | Safe in Perforation? | First-Line? | | --- | --- | --- | --- | --- | | **Ciprofloxacin** | P. aeruginosa, S. aureus | No | Yes | **Yes** | | Chloramphenicol | Broad spectrum | Minimal | Yes | No (2nd-line) | | Neomycin | Gram-negative | **Yes** | **No** | Contraindicated | | Acetic acid | Fungistatic/bacteriostatic | No | Yes | No (adjunct only) | **High-Yield:** Aminoglycosides (neomycin, gentamicin) are absolutely contraindicated in perforated CSOM due to ototoxicity risk and potential for permanent sensorineural hearing loss. **Clinical Pearl:** Systemic antibiotics (oral fluoroquinolones or amoxicillin-clavulanate) are reserved for acute exacerbations or when topical therapy fails; routine CSOM management relies on topical therapy combined with aural hygiene and ear cleaning.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.